Ever since the young indian protege Prithvi Shaw has received a back-dated eight-month suspension from the BCCI, there have been a lot of discussions regarding the same. He was found guilty of taking a prohibited substance, Terbutaline, which is generally found in cough syrups. His ban was stated to have started from March 16, 2019, and will continue until November 15, 2019.
Recently, the Board of Control for Cricket in India (BCCI) released a timeline in which it was stated that there was a gap of over two months between Shaw’s urine sample submission and the National Dope Testing Laboratory (NDTL) report. Even as Shaw gave the sample on February 22 during the Syed Mushtaq Ali Trophy, the results came on May 2. Even a reminder was sent on April 5.
In between, the young protege took part in the IPL and the T20 Mumbai League. He also trained at the National Cricket Academy during this while. Following all the chaos, the latest reports of India Today have suggested that the BCCI will now come under the ambit of the National Anti-Doping Agency. It means that the Indian team player will now be tested by the NADA.
For a long period of time, the BCCI has tried and avoided making using of NADA to test its cricketers. Now, the But the Indian cricket will now be undergoing a significant change. Describing the same, the BCCI anti-doping manager, Abhijit Salvi said, “If we would have been happy with NADA’s performance then BCCI would not have had an issue. I am sure you have read reports as well about NADA’s inefficiencies.”
Meanwhile, RS Julaniya, the Sports Secretary has expressed that the BCCI doesn’t have the discretion of saying any from now onwards.
He explained, “BCCI does not have the discretion to say no. All are same, everyone has to follow the same rule.”
As far as Shaw is concerned, he will be now be missing the action for the home series against South Africa and Bangladesh.